First Command Advisory Services, Inc.
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1727336
FORT WORTH, TX
Position in ALNY
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$3,970
+$2,778 QoQ
Shares Held
12
+300.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 25%
Shared 75%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026First Command Advisory Services, Inc. holds $143,852 across 14 Biotechnology names. ALNY ranks #5 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARQT |
Arcutis Biotherapeutics, Inc.
|
2,000 | $47,120 | |
| 2 | MRNA |
Moderna, Inc.
|
850 | $43,180 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
81 | $36,169 | |
| 4 | ARGX |
Argenx SE
|
6 | $4,381 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
12 | $3,970 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5 | $3,863 | |
| 7 | VKTX |
Viking Therapeutics, Inc.
|
90 | $2,928 | |
| 8 | INSM |
INSMED Inc
|
8 | $1,308 |
All Filings in ALNY
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,970 | 12 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,192 | 3 | Shares | Sole | 2026-02-11 | |
| No filing history on record for this holder in this stock. | ||||||